Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 327
2000 348
2001 316
2002 317
2003 435
2004 455
2005 503
2006 527
2007 454
2008 530
2009 497
2010 540
2011 515
2012 517
2013 517
2014 559
2015 508
2016 405
2017 412
2018 448
2019 460
2020 761
2021 1072
2022 792
2023 824
2024 572

Text availability

Article attribute

Article type

Publication date

Search Results

12,138 results

Results by year

Filters applied: . Clear all
Page 1
Comparative effectiveness of biological disease-modifying antirheumatic drugs and Janus kinase inhibitor monotherapy in rheumatoid arthritis.
Onishi A, Yamada H, Yamamoto W, Watanabe R, Hara R, Katayama M, Okita Y, Maeda Y, Amuro H, Son Y, Yoshikawa A, Hata K, Hashimoto M, Saegusa J, Morinobu A. Onishi A, et al. Rheumatology (Oxford). 2023 Nov 21:kead620. doi: 10.1093/rheumatology/kead620. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37988163
The metaverse: a new frontier for rheumatology.
Liebowitz JE. Liebowitz JE. Rheumatology (Oxford). 2024 Feb 1;63(2):267-268. doi: 10.1093/rheumatology/kead534. Rheumatology (Oxford). 2024. PMID: 37792478 No abstract available.
Bilateral scalp ulceration.
Firpo G, Jones G, Stewart L, Christie J. Firpo G, et al. Rheumatology (Oxford). 2024 May 2;63(5):e152-e153. doi: 10.1093/rheumatology/kead573. Rheumatology (Oxford). 2024. PMID: 37897698 No abstract available.
Real-world comparative study of the efficacy of Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study.
Hayashi S, Tachibana S, Maeda T, Yamashita M, Shirasugi I, Yamamoto Y, Yamada H, Okano T, Nishimura K, Ueda Y, Jinnno S, Saegusa J, Yamamoto W, Murata K, Fujii T, Hata K, Yoshikawa A, Ebina K, Etani Y, Yoshida N, Amuro H, Hashimoto M, Hara R, Katayama M, Okano T, Kuroda R. Hayashi S, et al. Rheumatology (Oxford). 2023 Nov 1:kead543. doi: 10.1093/rheumatology/kead543. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 37924201
Comorbidities in RA: bringing them to the limelight.
Nikiphorou E, Nash P. Nikiphorou E, et al. Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI235-SI236. doi: 10.1093/rheumatology/kead487. Rheumatology (Oxford). 2023. PMID: 37871916 No abstract available.
45 years in rheumatology.
Walker D. Walker D. Rheumatology (Oxford). 2024 Apr 2;63(4):904-905. doi: 10.1093/rheumatology/kead589. Rheumatology (Oxford). 2024. PMID: 37935418 No abstract available.
Sexual health in rheumatology.
Radhakrishna MH, Kayidhi S, Ravindran V. Radhakrishna MH, et al. Rheumatology (Oxford). 2024 Mar 1;63(3):584-586. doi: 10.1093/rheumatology/kead585. Rheumatology (Oxford). 2024. PMID: 37934139 No abstract available.
Lymphadenopathy in the rheumatology practice: a pragmatic approach.
Rodolfi S, Della-Torre E, Bongiovanni L, Mehta P, Fajgenbaum DC, Selmi C. Rodolfi S, et al. Rheumatology (Oxford). 2023 Dec 18:kead644. doi: 10.1093/rheumatology/kead644. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38109670
12,138 results
You have reached the last available page of results. Please see the User Guide for more information.